The market continues to firm up following a powerful rally in July after the worst first half of any year since the 1970’s. The big news driving gains continues to be a sense that inflation could be set to cool, allowing the US Federal Reserve to slow its pace of tightening. At the same time, […]
CYDY
Penny Stocks In Focus (CYDY, NWBO, ABML, HMBL)
CytoDyn Inc (OTCMKTS: CYDY) shares gained more than 8% closing the day at $0.73. CYDY has a market cap of over 524.8M$. CYDY is a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications. The company had announced the appointment of Dr. Cyrus Arman as President effective July 9, 2022. […]
Billionaire Investor Quietly Joins CYDY Board along with World Renown Cancer Researcher
CytoDyn Inc (CYDY) announced that Michael A. Klump joined the Board of Directors at CytoDyn. Mr. Klump has an extensive background in financing that traces back to Argonne Capital Group LLC. The timing of his appointment seems to be calculated as the company plans on courting suitors for licensing or acquisition deals with the […]
After Dropping to 52-Week Low, CytoDyn Starts Climbing Back Up (CYDY)
CytoDyn (OTC: CYDY), a developer of AIDS/HIV treatments, saw a $0.04, or 5.3%, increase today after slipping from $1.10 on July 5, 2012 to $0.76 at the closing bell yesterday. The stock opened at $0.80 this morning and went as high as $0.83 before dipping down to $0.76 and closing at $0.80. The stock reached […]
